BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35538489)

  • 1. MS: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer.
    Yin S; Yang L; Zheng Y; Zang R
    J Ovarian Res; 2022 May; 15(1):56. PubMed ID: 35538489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling.
    Yin S; Wang P; Yang L; Liu Y; Wang Y; Liu M; Qi Z; Meng J; Shi TY; Yang G; Zang R
    Oncotarget; 2016 May; 7(20):29359-70. PubMed ID: 27121065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer.
    Sopo M; Anttila M; Hämäläinen K; Kivelä A; Ylä-Herttuala S; Kosma VM; Keski-Nisula L; Sallinen H
    BMC Cancer; 2019 Jun; 19(1):584. PubMed ID: 31200683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway.
    Wu K; Li L; Li L; Wang D
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer.
    Wang W; Ren F; Wu Q; Jiang D; Li H; Shi H
    Oncol Rep; 2014 Nov; 32(5):2127-33. PubMed ID: 25176450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
    Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
    Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
    Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.
    Harjes U; Bridges E; Gharpure KM; Roxanis I; Sheldon H; Miranda F; Mangala LS; Pradeep S; Lopez-Berestein G; Ahmed A; Fielding B; Sood AK; Harris AL
    Oncogene; 2017 Feb; 36(7):912-921. PubMed ID: 27568980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
    Chen BY; Ye DF; Xie X; Chen HZ; Lü WG
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
    Ghosh S; Albitar L; LeBaron R; Welch WR; Samimi G; Birrer MJ; Berkowitz RS; Mok SC
    Gynecol Oncol; 2010 Oct; 119(1):114-20. PubMed ID: 20619446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
    Crasta JA; Mishra S; Vallikad E
    Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
    Hossein G; Halvaei S; Heidarian Y; Dehghani-Ghobadi Z; Hassani M; Hosseini H; Naderi N; Sheikh Hassani S
    Cancer Med; 2019 Aug; 8(9):4315-4329. PubMed ID: 31197964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
    Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats.
    Zonta YR; Martinez M; Camargo IC; Domeniconi RF; Lupi Júnior LA; Pinheiro PF; Reiter RJ; Martinez FE; Chuffa LG
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
    Vecchione A; Belletti B; Lovat F; Volinia S; Chiappetta G; Giglio S; Sonego M; Cirombella R; Onesti EC; Pellegrini P; Califano D; Pignata S; Losito S; Canzonieri V; Sorio R; Alder H; Wernicke D; Stoppacciaro A; Baldassarre G; Croce CM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9845-50. PubMed ID: 23697367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.